CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
Mijin Kim, Jee Hee Yoon, Jonghwa Ahn, Min Ji Jeon, Hee Kyung Kim, Dong Jun Lim, Ho-Cheol Kang, In Joo Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim
Endocrinol Metab. 2020;35(3):587-594.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.687

Excel Download

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
Endocrinology and Metabolism. 2020;35(3):587-594   Crossref logo
Link1 Link2 Link3

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Thyroid. 2020;   Crossref logo
Link1 Link2

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
OncoTargets and Therapy. 2011;209   Crossref logo
Link1

Vandetanib in advanced hereditary medullary thyroid cancer
Community Oncology. 2011;8(8):353-354   Crossref logo
Link1 Link2

Role of vandetanib in the management of medullary thyroid cancer
Biologics: Targets and Therapy. 2012;59   Crossref logo
Link1

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Yearbook of Endocrinology. 2012;2012:153-155   Crossref logo
Link1 Link2

Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer
BioDrugs. 2012;26(6):431-435   Crossref logo
Link1 Link2 Link3

Vandetanib—a new therapeutic option in advanced medullary thyroid cancer
Nature Reviews Endocrinology. 2011;8(1):1-1   Crossref logo
Link1 Link2 Link3

Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer
Endocrine. 2020;   Crossref logo
Link1 Link2 Link3

Surgical Management of Invasive Medullary Thyroid Carcinoma
Medullary Thyroid Cancer. 2016;127-136   Crossref logo
Link1